Atlas Trials

Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia

Clinical trial NCT04459676 · UNKNOWN

Trial details

NCT number
NCT04459676
Sponsor
Angion Biomedica Corp
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19Pneumonia
Start date
2020-07-31
Primary completion
2021-04-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.